文献速递慢性肾脏病遗传性与小管间质肾病

肾小管STAT3限制常染色体显性多囊肾病中的肾脏炎症

Tubular STAT3 Limits Renal Inflammation in Autosomal Dominant Polycystic Kidney Disease.
PubMed 文献 · J Am Soc Nephrol · 2020-04-01

该研究利用条件性小鼠模型(成年后敲除Pkd1、Stat3及纤毛)和纤毛缺陷或STAT3缺陷的肾小管细胞系,探讨STAT3在常染色体显性多囊肾病(ADPKD)中的作用。结果发现,多囊肾中STAT3活化主要通过原纤毛招募巨噬细胞间接发生;在Pkd1缺陷小管中灭活Stat3虽轻微减少囊肿负荷,却导致巨噬细胞和T细胞大量浸润,未能改善肾功能,且增加炎症趋化因子CCL5和CXCL10表达。结论提示STAT3并非ADPKD囊肿生长的关键驱动因素,而是通过抑制促炎细胞因子表达和限制免疫细胞浸润来塑造疾病表达。

要点

  • 多囊肾中STAT3活化主要通过原纤毛招募巨噬细胞间接发生。
  • 小管Stat3灭活轻微减少囊肿负荷但加重免疫细胞浸润,未改善肾功能。
  • STAT3抑制炎症趋化因子CCL5和CXCL10表达,限制免疫细胞浸润。

核心结论

  • STAT3并非ADPKD囊肿生长的关键驱动因素,而是通过限制炎症和免疫细胞浸润塑造疾病表达。

研究设计与样本

  • 研究使用条件性小鼠模型,涉及成年后敲除Pkd1、Stat3及纤毛,以及纤毛缺陷或STAT3缺陷的肾小管细胞系培养。

主要发现

  • 原纤毛在体外直接调节STAT3活化,但多囊肾中大部分STAT3活化通过原纤毛招募巨噬细胞间接发生。
  • 在Pkd1缺陷小管中灭活Stat3轻微减少囊肿负荷,但导致巨噬细胞和T细胞大量浸润,未改善肾功能。
  • Stat3灭活增加多囊肾和培养小管细胞中炎症趋化因子CCL5和CXCL10的表达。

临床怎么用

  • 提示靶向STAT3治疗ADPKD可能加重肾脏炎症和免疫细胞浸润,需谨慎评估。

局限性

  • 研究基于小鼠模型和细胞系,结果外推到人类ADPKD需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The inactivation of the ciliary proteins polycystin 1 or polycystin 2 leads to autosomal dominant polycystic kidney disease (ADPKD). Although signaling by primary cilia and interstitial inflammation both play a critical role in the disease, the reciprocal interactions between immune and tubular cells are not well characterized. The transcription factor STAT3, a component of the cilia proteome that is involved in crosstalk between immune and nonimmune cells in various tissues, has been suggested as a factor fueling ADPKD progression. METHOD: To explore how STAT3 intersects with cilia signaling, renal inflammation, and cyst growth, we used conditional murine models involving postdevelopmental ablation of Pkd1, Stat3, and cilia, as well as cultures of cilia-deficient or STAT3-deficient tubular cell lines. RESULTS: Our findings indicate that, although primary cilia directly modulate STAT3 activation in vitro, the bulk of STAT3 activation in polycystic kidneys occurs through an indirect mechanism in which primary cilia trigger macrophage recruitment to the kidney, which in turn promotes Stat3 activation. Surprisingly, although inactivating Stat3 in Pkd1-deficient tubules slightly reduced cyst burden, it resulted in a massive infiltration of the cystic kidneys by macrophages and T cells, precluding any improvement of kidney function. We also found that Stat3 inactivation led to increased expression of the inflammatory chemokines CCL5 and CXCL10 in polycystic kidneys and cultured tubular cells. CONCLUSIONS: STAT3 appears to repress the expression of proinflammatory cytokines and restrict immune cell infiltration in ADPKD. Our findings suggest that STAT3 is not a critical driver of cyst growth in ADPKD but rather plays a major role in the crosstalk between immune and tubular cells that shapes disease expression.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Viau A, Baaziz M, Aka A, et al. Tubular STAT3 Limits Renal Inflammation in Autosomal Dominant Polycystic Kidney Disease. J Am Soc Nephrol. 2020. PMID: 32238474. doi:10.1681/ASN.2019090959

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。